Investing
Top Analyst Upgrades and Downgrades (ABT, BLK, SAM, BREW, DVA, RE, FCX, AWAY, LNCO, TAP, PNR, TKC)
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Thursday.
Abbott Laboratories (NYSE: ABT) started as Outperform at William Blair.
BlackRock Inc. (NYSE: BLK) started as Overweight at J.P. Morgan.
Boston Beer Co. (NYSE: SAM) started as Neutral at Citigroup.
Craft Brew Alliance Inc. (NASDAQ: BREW) started as Neutral at Citigroup.
DaVita HealthCare Partners Inc. (NYSE: DVA) started as Overweight at JPMorgan.
EverestRe (NYSE: RE) raised to Overweight at J.P. Morgan.
Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) raised to Buy at Deutsche Bank.
HomeAway Inc. (NASDAQ: AWAY) raised to Overweight at Barclays.
LinnCo (NASDAQ: LNCO) started as Outperform at Wells Fargo.
Molson Coors Brewing Co. (NYSE: TAP) started as Neutral at Citigroup.
Partner Re (NYSE: PNR) cut to Underweight at J.P. Morgan.
Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) raised to Buy at BofA/Merrill Lynch.
Here are some other outside (and internal) outlook pieces for the end of 2012 and 2013:
JON C. OGG
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.